Sulfonamide compounds and medicinal use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 19, 2002
Grant Date -
N/A
app pub date -
Feb 14, 2000
filing date -
Jun 27, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A sulfonamide compound of the formula (I): R.sup.1 --SO.sub.2 NHCO--A--R.sup.2 (I) wherein R.sup.1 is alkyl, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R.sup.2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully